Layoff
Oct 2022Lucira announced cost-reduction plans and workforce reductions in 2022; later reporting said the combined reductions in force amounted to roughly 68% of the workforce.
SourceNext generation infectious disease test kits
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
Lucira Health was an Emeryville-based medical diagnostics company that pioneered single-use molecular infectious-disease testing, starting with an at-home COVID-19 test and later a combined COVID-19/flu test. The business went public in 2021, filed Chapter 11 in 2023, and was acquired by Pfizer; the branded product now appears as LUCIRA by Pfizer.
Primary product
LUCIRA® by Pfizer COVID-19 & Flu Home Test
Founded
2013
Headquarters
1412 62nd Street, Emeryville, California 94608
Team size
11-50
Industry
Medical Equipment Manufacturing
Sub-industry
Molecular infectious disease diagnostics
Offices
1412 62nd Street, Emeryville, California 94608
Open Positions
0 jobs at Lucira Health
No open positions
Check back later for new openings